Punicalagin Ameliorates Diabetic Cognitive Dysfunction by Inhibiting Neuroinflammation via the CX3CL1 / CX3CR1 Axis
Phytotherapy Research · 2026-01 · 40 (1) · 334-350
DOI: 10.1002/ptr.70133 ↗At a glance
Journal article in Phytotherapy Research, published online on 2025-11-27. Written by Rou Zhang and 6 co-authors. Institution: Xiangya School of Public Health, Central South University, Changsha, China. Major MEDLINE topics: Hydrolyzable Tannins, Cognitive Dysfunction, Diabetes Mellitus, Experimental, Chemokine CX3CL1. Cited 2 times so far (Crossref); 58 references. Funded by: Natural Science Foundation of Hunan Province, Natural Science Foundation of Changsha, Hunan Province.
Abstract (original language)
Diabetic cognitive dysfunction is a major complication of type 2 diabetes mellitus, with no effective therapy available. Punicalagin, a polyphenol compound, has demonstrated neuroprotective effects. This study aimed to explore the mechanism by which punicalagin ameliorates diabetic cognitive dysfunction, focusing on the inhibition of neuroinflammation. The type 2 diabetes mellitus model was established in vivo using a high‐fat diet combined with a streptozotocin injection, and in vitro using hyperglycemic conditions. The diabetic mice received punicalagin pretreatment for 10 weeks. HT22 and BV2 cells under hyperglycemic conditions were pretreated with punicalagin for 48 h. Underlying mechanisms were investigated using the Morris water maze test, western blotting, cellular immunofluorescence and co‐culture systems. Punicalagin reduced high blood glucose levels, alleviated learning and memory impairment, and attenuated neuroinflammation in diabetic mice. In addition, punicalagin promoted the expression of the CX3CL1/CX3CR1 axis and the Nrf2/HO‐1 pathway. Furthermore, the inhibitory effect of punicalagin on BV2 cell‐mediated neuroinflammation was attenuated after the inhibition of CX3CL1/CX3CR1 axis expression. These findings suggest that punicalagin ameliorates cognitive dysfunction and neuronal damage by attenuating neuroinflammation through activation of the CX3CL1/CX3CR1 signaling axis, offering a promising therapeutic strategy for diabetic cognitive dysfunction.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Xiangya School of Public Health, Central South University, Changsha, China.
ORCID profiles: Lina Yang
Funding
- Natural Science Foundation of Hunan Province
- Natural Science Foundation of Changsha, Hunan Province
Cite
APA
Zhang, R., Tan, X., Zhang, Y., Ma, Y., You, Z., Huang, Y., & Yang, L. (2026). Punicalagin Ameliorates Diabetic Cognitive Dysfunction by Inhibiting Neuroinflammation via the CX3CL1 / CX3CR1 Axis. Phytotherapy Research, 40(1), 334-350. https://doi.org/10.1002/ptr.70133
Vancouver
Zhang R, Tan X, Zhang Y, Ma Y, You Z, Huang Y, et al. Punicalagin Ameliorates Diabetic Cognitive Dysfunction by Inhibiting Neuroinflammation via the CX3CL1 / CX3CR1 Axis. Phytotherapy Research. 2026;40(1):334-350. doi:10.1002/ptr.70133
BibTeX
@article{Zhang2026,
author = {Zhang, Rou and Tan, Xiuying and Zhang, Yuhan and Ma, Yizhen and You, Ziyi and Huang, Yue and Yang, Lina},
title = {Punicalagin Ameliorates Diabetic Cognitive Dysfunction by Inhibiting Neuroinflammation via the CX3CL1 / CX3CR1 Axis},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {1},
pages = {334--350},
doi = {10.1002/ptr.70133}
}
EUVIMED